SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Translational Drug Development (TD2), a leading precision oncology contract research organization (CRO), and Deep Lens have announced a strategic partnership that will enhance access to tailored oncology treatments and novel clinical studies for patients receiving care in community oncology practices. The partnership will enable TD2 to offer Deep Lens’ proprietary clinical trial matching solution, VIPER(TM), as well as other research coordination services, to it
One thought on “”
Comments are closed.
It is my belief that mesothelioma will be the most deadly cancer. It’s got unusual attributes. The more I really look at it the more I am certain it does not conduct itself like a true solid tissue cancer. In the event mesothelioma is really a rogue viral infection, so there is the potential for developing a vaccine plus offering vaccination for asbestos open people who are at high risk regarding developing long term asbestos linked malignancies. Thanks for revealing your ideas for this important ailment.